Intercept Pharmaceuticals, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

793,321

Value ($000)

14,710

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	14,710	0.0%	793,321	9/30/2023
2023 Q2	8/11/2023	6,779	0.0%	612,967	6/30/2023
2023 Q1	5/15/2023	8,049	0.0%	599,338	3/31/2023
2022 Q4	2/13/2023	7,236	0.0%	584,994	12/31/2022
2022 Q3	11/14/2022	6,246	0.0%	447,778	9/30/2022
2022 Q2	8/12/2022	6,037	0.0%	437,207	6/30/2022
2022 Q1	5/13/2022	6,395	0.0%	393,063	3/31/2022
2021 Q4	2/11/2022	7,863	0.0%	482,740	12/31/2021
2021 Q3	11/12/2021	7,389	0.0%	497,636	9/30/2021
2021 Q2	8/13/2021	9,758	0.0%	488,665	6/30/2021
2021 Q1	5/12/2021	10,675	0.0%	462,540	3/31/2021
2020 Q4	2/12/2021	10,006	0.0%	405,127	12/31/2020
2020 Q3	11/13/2020	16,667	0.0%	402,015	9/30/2020
2020 Q2	8/13/2020	18,994	0.0%	396,462	6/30/2020
2020 Q1	5/14/2020	24,080	0.0%	382,469	3/31/2020
2019 Q4	2/13/2020	44,522	0.0%	359,282	12/31/2019
2014 Q1	5/14/2014	19,448	0.0%	58,973	3/31/2014
2013 Q4	2/14/2014	4,019	0.0%	58,861	12/31/2013